Researchers concluded, “CBD products do not have reliable CBD concentrations, both relative to the dose listed on the label and among individual gummies within the same bottle.”
Topic: CBD
“These data present CBD as a potential target to combat not only molecular deficits in AD but also cognitive impairment,” the study’s authors concluded.
Daily CBD consumption reduced participants’ alcohol cravings with “minimal side effects.”
Forty-nine percent of patients experienced a greater than 25 percent reduction in seizure frequency following CBD treatment.
On average, patients’ baseline pain fell 2.6 points on a 10-point numerical rating scale.
Eighty-one percent of participants reported reduced pain following their use of CBD products.
Researchers acknowledged improvements in patients’ anxiety, sleep quality, social effects, and behavior.
“Our results suggest that treatment with purified CBD is effective and safe” in autistic patients, investigators concluded.